Brief: Adiumentum Capital Fund I LP Says It Acquired Beneficial Ownership Of Atara Biotherapeutics Common Stock Shares In Belief Stock Was Undervalued
May 22 (Reuters) - Atara Biotherapeutics Inc ATRA.O :
* ADIUMENTUM CAPITAL FUND I LP SAYS ACQUIRED BENEFICIAL
OWNERSHIP
OF ATARA BIOTHERAPEUTICS COMMON STOCK SHARES IN BELIEF STOCK WAS
UNDERVALUED
* ADIUMENTUM CAPITAL FUND I LP: TO ENGAGE IN TALKS WITH
ATARA
BIOTHERAPEUTICS TO DISCUSS BUSINESS, FINANCIAL CONDITION,
STRATEGIC PLANS, GOVERNANCE
* ADIUMENTUM CAPITAL FUND I LP REPORTS 6.7% STAKE IN ATARA
BIOTHERAPEUTICS AS OF MAY 15- SEC FILING
Source text for Eikon: ID:n0001104659-24-064358
Further company coverage: ATRA.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Atara Biotherapeutics
See all newsAtara Biotherapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Atara Biotherapeutics Q2 revenue falls on deferred revenue recognition
Brief: Atara Biotherapeutics Q2 EPS USD -0.32
Atara Biotherapeutics, Inc. expected to post a loss of 31 cents a share - Earnings Preview
Brief: Atara Biotherapeutics - May Offer Up To $79.27 Million In Common Stock As Of May 12, 2026 - SEC Filing